ViiV Healthcare
在场
ViiV Healthcare 的所有者是 GSK.
是其中之一......
- Forbes Global 2000 (#183);
- Fortune 500 Europe (#104);
- FTSE 350;
- Global Fortune 500 (#400);
- Stoxx 600;
- TOB Iconic 10,000.
GSK 是一家在股票代码 GSK (GB) 下上市的公司。
GSK 在 20 个国家有直接业务。GSK 拥有 23家子公司，其中包括 Aiolos Bio、GSK ANZ 和 GSK APAC。
他们在：
涉及GSK的并购和融资。
- GSK has announced the acquisition of Aiolos Bio (公布2024一月12号).
- GSK has announced the acquisition of Bellus Health (公布2023四月19号).
高管
查看带有其 23 名主要高管的组织结构图
ViiV Healthcare 搜索最多的简介
- Deborah Waterhouse, Chief Executive Officer and Director
- Regis Simard, Director
- David Redfern, Chairman of the Board
创建提醒
跟踪 ViiV Healthcare 的高管变动
药店
GSK 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
药店 行业的其他推荐联系人
消息
ViiV Healthcare 的最新新闻稿
- ViiV Healthcare announces new strategic alliance to enable greater access to antiretroviral medicines in Brazil
- ViiV Healthcare announces superior efficacy of investigational, long-acting injectable formulation of cabotegravir dosed every two months over daily oral PrEP
- ViiV Healthcare presents positive data from first-ever implementation research study on how best to integrate a investigational once-monthly injectable HIV treatment in US healthcare practices
- ViiV Healthcare shares new data from Positive Perspectives, Wave 2 study, confirming a more holistic approach to HIV care can improve quality of life
- ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults with few treatment options available
- ViiV Healthcare to present new data on long-acting regimens for HIV prevention and treatment, alongside extensive insights into the evolving needs of people living with HIV at 23rd International AIDS Conference (AIDS 2020: Virtual)
- ViiV Healthcare announces grantees selected as part of £3 million Fund dedicated to HIV research and community-based programmes during COVID-19 pandemic
- Welsh Rugby star Gareth Thomas and ViiV Healthcare launch Tackle HIV campaign to address public misunderstanding and stigma associated with HIV
- Global HIV prevention study to stop early after ViiV Healthcare’s long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP
- ViiV Healthcare announces £3 million global fund to research the impact of COVID-19 on the HIV community and fill gaps in prevention, treatment and care during the pandemic
- View more press releases Close
通过电子邮件
